Al-Jefairi Nora, Burri Haran
Electrophysiology Unit, University Hospital of Geneva, Geneva, Switzerland.
Electrophysiology Unit, University Hospital of Geneva, Geneva, Switzerland.
Indian Heart J. 2014 Jan-Feb;66 Suppl 1(Suppl 1):S82-7. doi: 10.1016/j.ihj.2013.11.006. Epub 2013 Dec 22.
The implantable cardioverter-defibrillator (ICD) has established itself as life-saving therapy in patients at risk for sudden cardiac death. Remarkable technological advances have made ICDs easier and safer to implant, with improved therapeutic and diagnostic functions and reduced morbidity. Guidelines on ICD indications have been proposed by American and European scientific societies since a number of years, based upon trials and expert opinion. In the context of variable economic and political constraints, it is questionable whether these guidelines may be applied to all settings. This review discusses the guideline-based indications, critically examines their applicability to clinical practice, and discusses alternatives to ICD therapy.
植入式心脏复律除颤器（ICD）已成为对心脏性猝死高危患者的一种挽救生命的治疗方法。显著的技术进步使ICD植入更简便、更安全，其治疗和诊断功能得到改善，发病率降低。多年来，美国和欧洲的科学协会基于试验和专家意见提出了ICD适应症指南。在经济和政治限制各不相同的情况下，这些指南是否适用于所有情况值得怀疑。本综述讨论了基于指南的适应症，批判性地审视了它们在临床实践中的适用性，并讨论了ICD治疗的替代方法。
